Melanoma (stage III or IV) - ipilimumab: response to consultee, commentator and public comments on the Appraisal Consultation Document (ACD)
Melanoma (stage III or IV) - ipilimumab: response to consultee, commentator and public comments on the Appraisal Consultation Document (ACD)
02 November 2012 (352.9 Kb 42 sec) |
This page was last updated: 31 October 2012